Phagenesis
Company

Last deal

$42M

Amount

Series D

Stage

04.03.2024

Date

3

all rounds

$71.4M

Total amount

date founded

Financing round

General

About Company
Phagenesis develops a medical device for the treatment of dysphagia.

Industry

Sector :

Subsector :

founded date

01.01.2007

Number of employees

Company Type

For Profit

Last funding type

Series D

IPO status

Private

Description

The Phagenyx is a non-invasive device that has been rigorously tested in clinical trials and has been shown to significantly improve swallowing ability in patients with dysphagia. The company is committed to advancing the field of dysphagia care through innovative technology and evidence-based practices, working closely with healthcare providers and patients to ensure the highest standards of safety and efficacy.
Contacts
Legal Names

Legal name

Phagenesis Ltd
Similar Companies
995
Emphasys Medical

Emphasys Medical

Ephrasys Medical develops minimally invasive therapies for the treatment of chronic obstructive pulmonary diseases.

Sector

Medical Equipment and Services

Subsector

Medical Equipment

Keywords

Health Care, Medical, Medical Device

Location

Redwood City, CA, USA

total rounds

3

total raised

$67.7M
SzeleSTIM

SzeleSTIM

SzeleSTIM is a start-up that specialises in wearable electromedical devices for auricular vagus nerve stimulation.

Sector

Medical Equipment and Services

Subsector

Medical Equipment

Location

Vienna, Austria
Neuroloop

Neuroloop

The neuroloop is a platform to stimulate the vagal nerve for the treatment of chronic diseases.

Sector

Medical Equipment and Services

Subsector

Medical Equipment

Keywords

Health Care, Medical Device, Medical

Location

Freiburg im Breisgau, Germany
Parasym

Parasym

Parasym is a neurotechnology company that provides innovative neuromodulation products to improve quality of life.

Sector

Medical Equipment and Services

Subsector

Medical Equipment

Keywords

Health Care, Medical Device, Therapeutics

Location

London, UK
M&A Details
1

Acquired by

Nestlé Health Science

announced date

02.09.2016

Financials

Funding Rounds
5
3

Number of Funding Rounds

$71.4M

Money Raised

Their latest funding was raised on 04.03.2024. Their latest investor Aphelion Capital. Their latest round Series D

Date 
Funding Round 
Investors 
Money Raised 
Lead 
Sectoral Asset Management

Sectoral Asset Management

Sectoral Asset Management is a specialist in managing global investment portfolios in the healthcare sector.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Financial Services, Venture Capital, Asset Management

Location

Dorval, QC, Canada

count Of Investments

49

count Of Exists

6
Life Sciences Partners

Life Sciences Partners

LSP is a leading European investment firm that finances private and public life-science companies.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Biotechnology, Financial Services, Finance

Location

Amsterdam, Netherlands

count Of Investments

142

count Of Exists

29
MedTech Innovator

MedTech Innovator

MedTech Innovator is a global competition and accelerator for medical device, digital health and diagnostic companies.

Sector

Medical Equipment and Services

Subsector

Medical Equipment

Keywords

Health Care, Medical Device, Financial Services

Location

Los Angeles, CA, USA

count Of Investments

380

count Of Exists

18
Inventages Venture Capital Investment Inc.

Inventages Venture Capital Investment Inc.

Inventages Venture Capital Investment Inc is a Nestle SA investment arm that specializes in venture investments.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Location

London, UK

count Of Investments

33

count Of Exists

5
Co-Investors
Investors
7
4

Number of lead investors

7

Number of investors

Investor 
Lead 
Round 
Partners 
Aphelion Capital

Aphelion Capital

Aphelion Capital is a healthcare-focused venture capital firm that invests in innovative medical technology.

Sector

Closed End Investments

Subsector

Closed End Investments

Keywords

Health Care, Medical, Financial Services

Location

Mill Valley, CA 94941, USA

count Of Investments

35

count Of Exists

8
Sectoral Asset Management

Sectoral Asset Management

Sectoral Asset Management is a specialist in managing global investment portfolios in the healthcare sector.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Financial Services, Venture Capital, Asset Management

Location

Dorval, QC, Canada

count Of Investments

49

count Of Exists

6
Michael Sjostrom

Michael Sjostrom

Mr. Sjöström founded Sectoral Asset Management with Jérôme Pfund in 2000. Prior to establishing Sectoral, Mr. Sjöström worked for two Swiss banks and, in 1993, joined Pictet & Cie in Geneva as a pharmaceutical analyst. From 1994 until October 2000, he was the Portfolio Manager of Pictet Fund-Biotech and head of the pharma analyst team. Mr. Sjöström graduated in 1987 from the University of St.Gallen with an MBA in Finance and Economics. He obtained his CFA charter in 1996. In 1996, Mr. Sjöström co-founded the Swiss Society for Investment Professionals, the Swiss local society of the CFA Institute (formerly known as the Association for Investment Management and Research - AIMR).

current job

Sectoral Asset Management
Sectoral Asset Management
British Patient Capital

British Patient Capital

British Patient Capital invests in innovative UK companies to fuel their growth.

Sector

Closed End Investments

Subsector

Closed End Investments

count Of Investments

26

People

Founders
2

Shaheen Hamdy

current job

Phagenesis
Phagenesis

organization founded

1

Shaheen Hamdy

Conor Mulrooney
Conor Mulrooney

Conor Mulrooney

Conor Mulrooney is the COO and co-founder of Phagenesis®. He has over 15 years of product and business development experience in the medical devices and diagnostic sectors as a senior manager (MIMIT, UMIP, Tepnel PLC) or board representative (Myconostica, Iduron). He is the primary inventor in multiple patents in molecular biology, robotics and medical devices.

current job

Phagenesis
Phagenesis

organization founded

1

Conor Mulrooney

Employee Profiles
8
Scott Grant

Scott Grant

Vice President Therapy Development

Johnathon Kynaston

Office and clinical administrator and finance assistant

Reinhard Krickl

Reinhard Krickl

Chief Executive Officer

Tarja Barnes

Chief Financial Officer

Rebecca Sheridan

Head of Quality Assurance and Regulatory Affairs

Shaheen Hamdy

Co-Founder, CSO & Board Member

Conor Mulrooney

Conor Mulrooney

Co-Founder, COO & Board Member

Activity

Recent News
3